Stratifying risk and targeting immunosuppressive strategies

Area of Science:

• Nephrology
• Transplantation Immunology
• Immunosuppression Therapy

Background:

• Long-term outcomes in renal transplantation have stagnated despite short-term improvements.
• Late graft loss is frequently caused by chronic allograft nephropathy, driven by immunologic and non-immunologic insults.
• Current immunosuppressive regimens contribute to toxicity, a significant non-immunologic factor impacting graft survival.

Purpose of the Study:

• To address the multifactorial challenges in renal transplantation, including late graft loss and patient mortality.
• To explore strategies for reducing risks associated with immunosuppression, cardiovascular disease, malignancy, and infections in transplant recipients.
• To advocate for a personalized approach to immunosuppressive therapy based on individual recipient-donor risk profiles.

Main Methods:

• Review of current literature and clinical practices in renal transplantation.
• Discussion of immunologic and non-immunologic factors contributing to graft dysfunction and patient death.
• Consideration of donor factors and recipient-specific risk profiles for tailored treatment strategies.

Main Results:

• Renal transplant recipients face significant risks including chronic allograft nephropathy, cardiovascular disease, malignancy, and infections.
• Patient and graft survival are influenced by a complex interplay of recipient and donor-specific factors.
• Current immunosuppressive regimens present toxicity challenges impacting long-term allograft function.

Conclusions:

• A paradigm shift in clinical practice is necessary to improve long-term renal transplant outcomes.
• Flexible and individualized immunosuppressive strategies are crucial for managing diverse patient risk profiles.
• Addressing cardiovascular risk, malignancy, and infection alongside rejection prevention is essential for enhanced patient and graft survival.